Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/9017
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Myocardial effect compartment modeling of metoprolol and sotalol: importance of myocardial subsite drug concentration
Author: Ritchie, R.
Morgan, D.
Horowitz, J.
Citation: Journal of Pharmaceutical Sciences, 1998; 87(2):177-182
Publisher: AMER PHARMACEUTICAL ASSN
Issue Date: 1998
ISSN: 0022-3549
1520-6017
Abstract: We have recently reported the time course of acute myocardial drug uptake and simultaneous pharmacodynamic effects for metoprolol (4 mg; n = 12) and sotalol (20 mg; n = 10) in patients with ischemic heart disease. The acute pharmacodynamic effects of the two drugs included reductions in both spontaneous heart rate and the contractile index peak positive rate of left ventricular pressure rise and prolongation of the electrocardiographic PR interval, all of which exhibited an equilibration delay compared with myocardial drug content. The objective of the current study was to analyze the relationship between myocardial drug content and effect for both metoprolol and sotalol using an effect compartment model, to examine the potential for the two drugs to share a common subsite of action in the myocardium. The time course of myocardial drug content was best described by a one-compartment model for metoprolol and a two-compartment model for sotalol. A linear pharmacodynamic model, relating the amount of drug at the effect-site (Ae) with each of the three effects, was used in the effect compartment modeling. The slope of each of these effects as a function of Ae was considerably flatter for sotalol than for metoprolol, reflecting the relative beta-adrenoceptor antagonistic potencies of the two drugs. The exit rate constant from the effect compartment (K(eo)) did not differ significantly from each other or from the exit rate constant from the "peripheral" compartment (K21) for sotalol. The results suggest that the effect compartment within the myocardium for both drugs may correspond to a "peripheral" compartment, even though a "peripheral" pharmacokinetic compartment for myocardial metoprolol content was not apparent. Thus, the effect compartment for many cardioactive drugs may correspond to a pharmacokinetically "peripheral" compartment, irrespective of localization of effect to a small (e.g. sinoatrial node) or large (e.g. ventricular myocardium) region of the heart.
Keywords: Myocardium
Humans
Sotalol
Metoprolol
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Injections, Intravenous
Area Under Curve
Linear Models
Regression Analysis
Heart Rate
Myocardial Contraction
Depression, Chemical
Models, Biological
DOI: 10.1021/js9702776
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.